These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 8238242

  • 1. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas.
    Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR.
    Am J Pathol; 1993 Nov; 143(5):1255-62. PubMed ID: 8238242
    [Abstract] [Full Text] [Related]

  • 2. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.
    Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF.
    Cancer Res; 1993 Oct 01; 53(19):4727-35. PubMed ID: 8402650
    [Abstract] [Full Text] [Related]

  • 3. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.
    Guidi AJ, Abu-Jawdeh G, Tognazzi K, Dvorak HF, Brown LF.
    Cancer; 1996 Aug 01; 78(3):454-60. PubMed ID: 8697391
    [Abstract] [Full Text] [Related]

  • 4. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Brown LF, Tognazzi K, Dvorak HF, Harrist TJ.
    Am J Pathol; 1996 Apr 01; 148(4):1065-74. PubMed ID: 8644848
    [Abstract] [Full Text] [Related]

  • 5. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.
    Brown LF, Detmar M, Tognazzi K, Abu-Jawdeh G, Iruela-Arispe ML.
    Lab Invest; 1997 Feb 01; 76(2):245-55. PubMed ID: 9042161
    [Abstract] [Full Text] [Related]

  • 6. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF, Brown LF.
    Lab Invest; 1996 Jun 01; 74(6):1105-15. PubMed ID: 8667614
    [Abstract] [Full Text] [Related]

  • 7. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.
    Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF.
    J Exp Med; 1994 Jul 01; 180(1):341-6. PubMed ID: 8006592
    [Abstract] [Full Text] [Related]

  • 8. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF.
    Clin Cancer Res; 1999 May 01; 5(5):1041-56. PubMed ID: 10353737
    [Abstract] [Full Text] [Related]

  • 9. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer.
    Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL, Schnitt SJ.
    Hum Pathol; 1995 Jan 01; 26(1):86-91. PubMed ID: 7821921
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions.
    Brown LF, Olbricht SM, Berse B, Jackman RW, Matsueda G, Tognazzi KA, Manseau EJ, Dvorak HF, Van de Water L.
    J Immunol; 1995 Mar 15; 154(6):2801-7. PubMed ID: 7876550
    [Abstract] [Full Text] [Related]

  • 12. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.
    Wizigmann-Voos S, Breier G, Risau W, Plate KH.
    Cancer Res; 1995 Mar 15; 55(6):1358-64. PubMed ID: 7533661
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.
    Clin Cancer Res; 2000 Mar 15; 6(3):957-65. PubMed ID: 10741721
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma.
    Skobe M, Brown LF, Tognazzi K, Ganju RK, Dezube BJ, Alitalo K, Detmar M.
    J Invest Dermatol; 1999 Dec 15; 113(6):1047-53. PubMed ID: 10594750
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.